Treating Acute Leukemias
in the Asia-Pacific Region
A Worldwide Collaboration to Define and Refine the Most Effective Treatments in Leukemias
Overview
In recent years, progress in the understanding of acute leukemias has led to novel therapies that are rapidly changing treatment paradigms. Aptitude Health developed the Global Leukemia Academy to help physicians who treat acute leukemias bridge the gap between innovation and implementation for patient care.
Date and Location
December 5–6, 2022, Webinar
Meeting Content
Day 1
View videos per session
 |
What’s New in ALL? Recent Developments in Research and Management Hagop Kantarjian |
|
The Clinical Value of MRD in ALL: How MRD Can Guide the Use of Targeted Agents or Immunotherapy Jae Park |
|
Recent Insights in Genetic Variants in ALL: Ph+ and Ph-Like Elias Jabbour |
|
Current and Future Role of Transplantation in ALL Marco de Lima |
|
Debate: How to Optimally Sequence CD19-Targeted Approaches in ALL Shaun Fleming and Jae Park |
|
Changing Landscape of Treatment Options in Pediatric and AYA ALL Stephen H. Hunger |
|
AYA Patient Case Discussion and Debate: The Evolving Concept of Transplantation in AYA Michael Osborn and Marcos de Lima |
|
Interactive Discussion: Regional Challenges of ALL management Shaun Fleming and Michael Osborn |
Day 2 Adult Breakout Session
View videos per session
|
Optimizing First-Line Therapy in Adult and Older ALL: Integration of Immunotherapy Into Frontline Regimens Elias Jabbour |
|
Current Treatment Options for Relapsed ALL in Adult and Elderly Patients Jae Park |
|
ALL Case-Based Panel Discussion Huai-Hsuan Huang and Michael Ashby |
|
Beyond the Horizon: New and Future Treatment Approaches for Adult and Older ALL Jae Park |
|
Interactive Discussion: Treatment Landscape Evolution Elias Jabbour |
Day 2 Pediatric ALL Breakout Session
View videos per session
|
Optimizing First-Line Therapy in Pediatric ALL: How to Balance Cure and Long-term Risks? Michael Osborn |
|
Optimal Management and Treatment Coordination of Long-term Toxicities in Pediatric ALL Stephanie Dixon |
|
ALL Case-Based Panel Discussion Savenaca Seduadua and Claudia Toro |
|
Current Treatment Options for Relapsed ALL in Children Elizabeth Raetz |
|
ALL Case-Based Panel Discussion Miri Tukana |
Chair
Elias Jabbour, MD
MD Anderson Cancer Center,
USA
Faculty
Stephanie Dixon, MD, MPH
St. Jude Children’s Research Hospital, USA
Shaun Fleming, MBBS(Hons), FRACP, FRCPA
Melbourne Haematology, Richmond, VIC, Australia
Hagop Kantarjian, MD
MD Anderson Cancer Center, USA
Marcos de Lima, MD
Ohio State University, USA
Michael Osborn, MBBS, FRACP, FRCPA
SA Pathology, Adelaide, Australia
Jae Park, MD
Memorial Sloan Kettering Cancer Center, USA
Elizabeth Raetz, MD
New York University Grossman School of Medicine, USA
Stephen P. Hunger, MD
Children’s Hospital of Philadelphia, USA
Agenda
This 2-day interactive virtual meeting with global experts will focus on the management of patients with acute leukemia in various countries within the Asia-Pacific region.
DAY 1: Follow presentations, join a debate on sequencing CD19-targeted strategies (systemic therapies vs CAR T), and engage with the faculty in panel discussions on optimal treatment, patient access, and regional challenges across the Asia-Pacific region.
DAY 2: Join the pediatric or adult breakout session to learn about the treatment strategies for newly diagnosed and relapsed/refractory leukemia patients and attend the patient case-based panel discussions focusing on toxicity management.
Day 1 – PLENARY SESSIONS Monday, December 5, 2022
9.00 AM – 12.30 PM (GMT +8) Shanghai
10.00 AM – 1.30 PM (GMT +9) Tokyo
12.00 PM – 3.30 PM (GMT +11) Sydney
| Time (GMT +8) | Topic | Presenter |
| 9.00 AM – 9.10 AM |
Welcome and Meeting Overview | Elias Jabbour |
| 9.10 AM – 9.30 AM |
What’s New in ALL? Recent Developments in Research and Management
|
Hagop Kantarjian |
| 9.30 AM – 9.50 AM |
The Clinical Value of MRD in ALL: How MRD Can Guide the Use of Targeted Agents or Immunotherapy
|
Jae Park |
| 9.50 AM – 10.10 AM |
Recent Insights in Genetic Variants in ALL: Ph+ and Ph-Like | Elias Jabbour |
| 10.10 AM – 10.30 AM |
Current and Future Role of Transplantation in ALL | Marcos de Lima |
| 10.30 AM – 11.00 AM |
Debate: How to Optimally Sequence CD19-Targeted Approaches in ALL
|
Moderator: Elias Jabbour Shaun Fleming, and Jae Park All faculty |
| 11.00 AM – 11.10 AM |
Break | |
| 11.10 AM – 11.30 AM |
Changing Landscape of Treatment Options in Pediatric and AYA ALL
|
Stephen P. Hunger |
| 11.30 AM – 11.55 AM |
AYA Patient Case Discussion and Debate: The Evolving Concept of Transplantation in AYA | Michael Osborn, and Marcos de Lima |
| 11.55 AM – 12.20 PM |
Interactive Discussion: Regional Challenges of ALL Management
|
Moderators: Shaun Fleming, and Michael Osborn All faculty |
| 12.20 PM – 12.30 PM |
Session Close | Elias Jabbour |
Day 2 – Virtual Breakout – Adult ALL Sessions Tuesday, December 6, 2022
9.00 AM – 11.45 AM (GMT +8) Shanghai
10.00 AM – 12.45 PM (GMT +9) Tokyo
12.00 PM – 2.45 PM (GMT +11) Sydney
| Time (GMT +8) | Topic | Presenter |
| 9.00 AM – 9.10 AM |
Session Open
|
Elias Jabbour |
| 9.10 AM – 9.35 AM |
Optimizing First-Line Therapy in Adult and Older ALL: Integration of Immunotherapy Into Frontline Regimens
|
Elias Jabbour |
| 9.35 AM – 10.00 AM |
Current Treatment Options for Relapsed ALL in Adult and Elderly Patients
|
Jae Park |
| 10.00 AM – 10.40 AM |
ALL Case-Based Panel Discussion
|
Moderators: Shaun Fleming, and Elias Jabbour Huai-Hsuan Huang Michael Ashby All faculty |
| 10.40 AM – 10.50 AM |
Break | |
| 10.50 AM – 11.10 AM |
Beyond the Horizon: New and Future Treatment Approaches for Adult and Older ALL
|
Jae Park |
| 11.10 AM – 11.35 AM |
Interactive Discussion: Treatment Landscape Evolution
|
Moderator: Elias Jabbour All faculty |
| 11.35 AM – 11.45 AM |
Session Close | Elias Jabbour |
Day 2 – Virtual Breakout – Pediatric ALL Sessions Tuesday, December 6, 2022
9.00 AM – 11.45 AM (GMT +8) Shanghai
10.00 AM – 12.45 PM (GMT +9) Tokyo
12.00 PM – 2.45 PM (GMT +11) Sydney
| Time (GMT +8) | Topic | Presenter |
| 9.00 AM – 9.10 AM |
Session Open
|
Elizabeth Raetz |
| 9.10 AM – 9.40 AM |
Optimizing First-Line Therapy in Pediatric ALL: How to Balance Cure and Long-term Risks?
|
Michael Osborn |
| 9.40 AM – 10.00 AM |
Optimal Management and Treatment Coordination of Long-term Toxicities in Pediatric ALL
|
Stephanie Dixon |
| 10.00 AM – 10.40 AM |
ALL Case-Based Panel Discussion
|
Moderators: Michael Osborn, and Elizabeth Raetz Savenaca Seduadua Claudia Toro |
| 10.40 AM – 10.50 AM |
Break | |
| 10.50 AM – 11.15 AM |
Current Treatment Options for Relapsed ALL in Children
|
Elizabeth Raetz |
| 11.15 AM – 11.35 AM |
ALL Case-Based Panel Discussion
|
Moderators: Michael Osborn, and Elizabeth Raetz Miri Tukana All faculty |
| 11.35 AM – 11.45 AM |
Session Close | Elizabeth Raetz |
